nafamostat has been researched along with Carotid Artery Narrowing in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sawada, M | 1 |
| Yanamoto, H | 1 |
| Nagata, I | 1 |
| Hashimoto, N | 1 |
| Nakahara, I | 1 |
| Akiyama, Y | 1 |
| Kikuchi, H | 1 |
| Macdonald, RL | 1 |
1 other study available for nafamostat and Carotid Artery Narrowing
| Article | Year |
|---|---|
Prevention of neointimal formation by a serine protease inhibitor, FUT-175, after carotid balloon injury in rats.
Topics: Animals; Benzamidines; Carotid Stenosis; Guanidines; Male; Rats; Rats, Sprague-Dawley; Serine Protei | 1999 |